Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Olson

Showing results (431-440 of 481) with videos related to

Pageof 49
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2011
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasisCarla G Monico, Sandro Rossetti, Ruth Belostotsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2021
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2Prince Singh, Jason K Viehman, Ramila A Mehta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type miceNicole K Paulk, Karsten Wursthorn, Annelise Haft, et al.
Cytogenetic and Genome Research|September 10, 2009
Topo IIIalpha and BLM act within the Fanconi anemia pathway in response to DNA-crosslinking agentsA W Hemphill, Y Akkari, A H Newell, et al.
JAMA|September 9, 2004
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in womenTimothy R Wessel, Christopher B Arant, Marian B Olson, et al.
Psychosomatic Medicine|December 26, 2007
Depression, the metabolic syndrome and cardiovascular riskViola Vaccarino, Candace McClure, B Delia Johnson, et al.
Leukemia & Lymphoma|March 8, 2022
Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcomeWei Xie, Philipp W Raess, Jennifer Dunlap, et al.
Critical Care Explorations|December 12, 2022
Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort StudyAditya A Mohan, Lyra B Olson, Ibtehaj A Naqvi, et al.
Oncotarget|October 27, 2017
Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancerJennifer Podolak, Kristi Eilers, Timothy Newby, et al.
Circulation|February 19, 2004
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)B Delia Johnson, Kevin E Kip, Oscar C Marroquin, et al.
Pageof 49

Showing results (431-440 of 481) with videos related to

Sort By:
Pageof 49
Clinical Journal of the American Society of Nephrology : CJASN|September 8, 2011
Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasisCarla G Monico, Sandro Rossetti, Ruth Belostotsky, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2021
Clinical characterization of primary hyperoxaluria type 3 in comparison with types 1 and 2Prince Singh, Jason K Viehman, Ramila A Mehta, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2012
In vivo selection of transplanted hepatocytes by pharmacological inhibition of fumarylacetoacetate hydrolase in wild-type miceNicole K Paulk, Karsten Wursthorn, Annelise Haft, et al.
Cytogenetic and Genome Research|September 10, 2009
Topo IIIalpha and BLM act within the Fanconi anemia pathway in response to DNA-crosslinking agentsA W Hemphill, Y Akkari, A H Newell, et al.
JAMA|September 9, 2004
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in womenTimothy R Wessel, Christopher B Arant, Marian B Olson, et al.
Psychosomatic Medicine|December 26, 2007
Depression, the metabolic syndrome and cardiovascular riskViola Vaccarino, Candace McClure, B Delia Johnson, et al.
Leukemia & Lymphoma|March 8, 2022
Adult acute myeloid leukemia patients with <i>NUP98</i> rearrangement have frequent cryptic translocations and unfavorable outcomeWei Xie, Philipp W Raess, Jennifer Dunlap, et al.
Critical Care Explorations|December 12, 2022
Age and Comorbidities Predict COVID-19 Outcome, Regardless of Innate Immune Response Severity: A Single Institutional Cohort StudyAditya A Mohan, Lyra B Olson, Ibtehaj A Naqvi, et al.
Oncotarget|October 27, 2017
Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancerJennifer Podolak, Kristi Eilers, Timothy Newby, et al.
Circulation|February 19, 2004
Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE)B Delia Johnson, Kevin E Kip, Oscar C Marroquin, et al.
Pageof 49